Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.

Pile of papers with bright paperclips © Shutterstock

The living reviews will summarise literature around one topic and are a response to the speed and volume of COVID-19 immunology research published during the pandemic.

On behalf of the Oxford-Cardiff COVID-19 Literature Consortium, Dr Ewoud Compeer, University of Oxford points out the idea behind this new publishing format: "The field of COVID-19 immunology was seeing new developments and new hypotheses appearing at an extreme pace online in the form of pre-prints. This speed of publishing made literature reviews outdated even before a journal published them. Our 'living reviews' will stay "live" for a designated period, being updated as change happens."

The journal publishes peer reviewed scientific articles, and the annotation enables rapid communication of updated information, but the version of record does not change so provides a history of the scientific developments.

Professor Awen Gallimore, Cardiff University finds similar advantages to the 'live' format of reviews: "Because new information emerges day by day, when you publish something on Monday by the following Friday it may already be out of date. Our living reviews enable as-you-go updates and should represent a useful step towards supporting scientists address the big and trending research questions."

The COVID-19 Literature initiative began with a team of around 100 post-doctoral researchers, DPhil students, and faculty members from the Medical Sciences Division at the University of Oxford reading, reviewing and summarising the latest COVID-19 research from all round the world in order to support frontline researchers.

At Cardiff, the School of Medicine-wide Journal Club, also comprising PhD students, post-docs and ECRs had started a similar initiative. Oxford and Cardiff joined forces to pool expertise around a wider range of disciplines and ensure those on the frontline were up to date with the latest developments in the field.

The living reviews add to a growing body of material from the Oxford-Cardiff COVID-19 Literature Consortium that is available through their website, and popular science blog, and could become a new benchmark for reviewing research in the future.

"We are pleased to be able to support the research community with this new series of Living Reviews from the Oxford-Cardiff COVID-19 Literature Consortium. We're excited to be able to offer this new open annotation functionality to our authors in Oxford Open Immunology and hope that this innovative new format will generate a useful and up to date resource for readers," said Rhiannon Meaden, Senior Publisher at OUP.

"The reviews were like a paint-by-numbers, we knew there were bits missing and new colours were coming in week by week, but it would be years before we got the whole picture," said Luke Davies from Cardiff University, one of the authors of the first published review. "A living review allows us to carefully add to the picture over time, while still delivering an up-to-date snapshot of the field that can aid ongoing research."

The first living reviews to be published are: Viral entry, sensing and evasion, and Dysregulated inflammation drives immunopathology.

 

 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.